Is immunotherapy re-entering the kidney cancer arena from the back door? Considerations from the Phase I/II study of siltuximab
Porta, Camillo, Pedrazzoli, Paolo, Paglino, ChiaraТом:
3
Мова:
english
Журнал:
Immunotherapy
DOI:
10.2217/imt.11.19
Date:
April, 2011
Файл:
PDF, 343 KB
english, 2011